Olfactogustatory Perception, Eating Behaviour and Inflammation in Crohn's Disease
NCT ID: NCT02859675
Last Updated: 2024-02-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
62 participants
OBSERVATIONAL
2013-10-07
2021-05-03
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Intermittent Caloric Restriction in Patients With Mild to Moderate Crohn's Disease
NCT05683730
Study of Dietary Composition in Crohn's Disease
NCT04431700
Study of Factors and Mechanisms Influencing the Effects of Treatments in Crohn's Disease
NCT04135027
Reduced Appetite in Crohn's Disease: The Role of the Brain in the Control of Food Intake
NCT02772458
Phenotyping of Adult Crohn's Focusing on Sarcopenia
NCT05572203
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Crohn and anti-TNF treatment
Tests at 3 or 4 weeks after the beginning of anti-TNF treatment
triangular test
metabolic state, impedance measurement, potential flavours evoked by sucrose,
blood sampling
sampling of 2 mL
Questionnaires
Stunkard, PrefQuest
Crohn and without anti-TNF treatment
tests performed according to patient availability
triangular test
metabolic state, impedance measurement, potential flavours evoked by sucrose,
blood sampling
sampling of 2 mL
Questionnaires
Stunkard, PrefQuest
Control
tests performed according to patient availability
triangular test
metabolic state, impedance measurement, potential flavours evoked by sucrose,
blood sampling
sampling of 2 mL
Questionnaires
Stunkard, PrefQuest
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
triangular test
metabolic state, impedance measurement, potential flavours evoked by sucrose,
blood sampling
sampling of 2 mL
Questionnaires
Stunkard, PrefQuest
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of Crohn's disease according to clinical, endoscopic, histological, radiological and biochemical criteria as defined by the European Consensus Conference,
* Men or women who have provided consent and willing to cooperate.
* Adult person
* Without follow-up for a chronic pathology
* Having given its consent
Exclusion Criteria
* Intercurrent disease (diabetes and metabolic disease, liver cirrhosis, progressive cancer, acute or chronic infection, Human Immunodeficiency Virus HIV),
* Organ failure (respiratory, heart, or renal failure, neurological disorders),
* Intolerance to gluten,
* Treatments (other than those used for Crohn's disease) able to interfere with food intake,
* Aversion to foods consumed or smelled,
* Poor understanding of cognitive tasks required.
* Crohn's disease complicated by an abscess or infectious complication
* Acute Crohn's disease defined by a CDAI score \> 150
For Controls:
* Protected adult
* Person not affiliated to a social security system
* Pregnant or breastfeeding woman
* Active smoker
* No one who does not speak French
* Taking treatment that interferes with taste or acts on the central nervous system
18 Years
60 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire Dijon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Hospitalier Universitaire
Dijon, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BRONDEL Ass INRA 2011
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.